臨床医の期待は,プラセボの鎮痛作用に影響する.

Using fMRI to evaluate the effects of milnacipran on central pain processing in patients with fibromyalgia.

Scandinavian journal of pain·2018

Painful Temporomandibular Disorder: Decade of Discovery from OPPERA Studies.

Journal of dental research·2016

Differential psychophysiological effects of operant and cognitive behavioural treatments in women with fibromyalgia.

European journal of pain (London, England)·2016

Osteoarthritis pain mechanisms: basic studies in animal models.

Osteoarthritis and cartilage·2013

Sleep apnea symptoms and risk of temporomandibular disorder: OPPERA cohort.

Journal of dental research·2013

Neurosensory assessments of migraine.

Brain research·2013

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Intravenous Low-dose Buprenorphine for Acute Pain Management in the Emergency Department: A Case Series.

Clinical practice and cases in emergency medicine·2026

Comparative bioavailability of three benznidazole formulations in healthy individuals: a randomised study.

Memorias do Instituto Oswaldo Cruz·2026

A Regulatory-Ready Bayesian Evidence Framework across Clinical Development and Pharmacovigilance: Practical Expectations from FDA, EMA, and ICH Guidance.

Therapeutic innovation & regulatory science·2026

Patient Access to Buprenorphine at Community Pharmacies: A Scoping Review of Audit Studies.

Journal of addiction medicine·2026

Immunomodulatory Activity of Phenylephrine on LPS Stimulated Macrophages.

Immunopharmacology and immunotoxicology·2026

Postoperative Mortality Following Extended-Release Buprenorphine, Carprofen, and Bupivacaine Administration in Male ACI Rats (Rattus norvegicus).

Journal of the American Association for Laboratory Animal Science : JAALAS·2026

関連する実験動画

臨床医の期待は,プラセボの鎮痛作用に影響する

関連する概念動画

Using fMRI to evaluate the effects of milnacipran on central pain processing in patients with fibromyalgia.

Painful Temporomandibular Disorder: Decade of Discovery from OPPERA Studies.

Differential psychophysiological effects of operant and cognitive behavioural treatments in women with fibromyalgia.

Osteoarthritis pain mechanisms: basic studies in animal models.

Sleep apnea symptoms and risk of temporomandibular disorder: OPPERA cohort.

Neurosensory assessments of migraine.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Intravenous Low-dose Buprenorphine for Acute Pain Management in the Emergency Department: A Case Series.

Comparative bioavailability of three benznidazole formulations in healthy individuals: a randomised study.

A Regulatory-Ready Bayesian Evidence Framework across Clinical Development and Pharmacovigilance: Practical Expectations from FDA, EMA, and ICH Guidance.

Patient Access to Buprenorphine at Community Pharmacies: A Scoping Review of Audit Studies.

Immunomodulatory Activity of Phenylephrine on LPS Stimulated Macrophages.

Postoperative Mortality Following Extended-Release Buprenorphine, Carprofen, and Bupivacaine Administration in Male ACI Rats (Rattus norvegicus).

関連する実験動画

臨床医の期待は,プラセボの鎮痛作用に影響する

関連する概念動画

関連記事